USP-NF Stimuli Article on Linearity of Measurement Methods
Recommendation

Thursday, 29 October 2026 9 .00 - 14.00 h
Practical Approaches for Assessing the Risks of Impurities
In the Pharmacopeial Forum, PF 48(5), a stimuli article entitled "Linearity of Measurement Methods" was published.
According to the authors, Edwin van den Heuvel, Brent Harrington, and Timothy Schofield, the "article provides a very generic definition of linearity that is useful to support both method calibration and accuracy studies, making it possible to discuss linearity for quantal bioassays, and support the life cycle of the method."
The article starts with an Introduction, in which general concepts are referenced, as they are, for example, outlined in ICH Q2(R1), ICH Q2(R2) as well as the USP chapters <1220> Analytical Procedure Life Cycle, <1225> Validation of Compendial Procedures, <1210> Statistical Tools for Procedure Validation, and <1030> Biological Assay Chapters—Overview and Glossary.
It continues with a brief overview of the Accuracy Experiment to investigate accuracy as proposed in validation guidelines like USP <1225> and ICH Q2(R1). After that, in the subchapter on Linearity Enhances Accuracy Understanding, the concepts of proportional and absolute bias are discussed in the context of analytical linearity.
In the following subchapter (General Definition of Linearity), a generic mathematical definition of linearity is provided, followed by sections providing discussions on Estimation of Linearity, Sources of Linearity Violation, and Evaluating Linearity and Proportionality.
The subsequent section provides three Examples:
- 1. An analytical method, where the authors develop the calibration model and investigate the accuracy of the calibration model;
- 2. An investigation of the linearity of a microbiological method;
- 3. An investigation of linearity for the true relative potency around the target value.
The document ends with a final Discussion and references to Additional Information.
The article is available on PF Online via the USP Website Access Point. The deadline for submitting comments is November 30, 2022.
Related GMP News
21.10.2026EMA Updates Information Page on Bioequivalence Guidelines
21.10.2026BP Publishes new Draft Texts
21.10.2026FDA Identifies Critical Deficiencies in Analytical Testing and CGMP Oversight
07.10.2026Analytical Quality Group Developments May through August 2026
07.10.2026Two New FDA Warning Letters Put OOS Investigations in Focus
07.10.2026Pharmeuropa: Revision Proposed for Chapter 2.5.32 on Coulometric Karl Fischer Water Determination

